Covered recipient · General Payments record
TYLER SELIG
General Payments · PY2023–2025
$2,277.70
- Reported across 51 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,222.35 | 25 |
| Education | $84.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $832.13 | 14 |
| Gilead Sciences, Inc. | $152.26 | 2 |
| Janssen Biotech, Inc. | $131.53 | 3 |
| Lilly USA, LLC | $121.97 | 4 |
| Ipsen Biopharmaceuticals, Inc | $27.26 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $21.01 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.08 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160862 | CMS |
| ABBVIE INC. | $31.37 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160867 | CMS |
| ABBVIE INC. | $122.31 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160872 | CMS |
| ABBVIE INC. | $27.21 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160879 | CMS |
| ABBVIE INC. | $30.44 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160884 | CMS |
| ABBVIE INC. | $19.86 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160890 | CMS |
| ABBVIE INC. | $29.09 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160897 | CMS |
| ABBVIE INC. | $125.27 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160902 | CMS |
| ABBVIE INC. | $28.30 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160913 | CMS |
| ABBVIE INC. | $23.53 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160917 | CMS |
| ABBVIE INC. | $14.89 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160925 | CMS |
| ABBVIE INC. | $113.69 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160930 | CMS |
| ABBVIE INC. | $147.34 | 10/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160935 | CMS |
| ABBVIE INC. | $94.75 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204160940 | CMS |
| Gilead Sciences, Inc. | $22.06 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234504593 | CMS |
| Gilead Sciences, Inc. | $130.20 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234380478 | CMS |
| Intercept Pharmaceuticals, Inc. | $21.01 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249878218 | CMS |
| Ipsen Biopharmaceuticals, Inc | $27.26 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208881030 | CMS |
| Janssen Biotech, Inc. | $21.26 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174714426 | CMS |
| Janssen Biotech, Inc. | $26.27 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174715149 | CMS |
| Janssen Biotech, Inc. | $84.00 | 09/24/2025 | Education | Undisputed | 06/30/2026 | 1174711123 | CMS |
| Lilly USA, LLC | $33.24 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187060390 | CMS |
| Lilly USA, LLC | $30.57 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187053795 | CMS |
| Lilly USA, LLC | $31.86 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186981342 | CMS |
| Lilly USA, LLC | $26.30 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186990236 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.19 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223768381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.